NT5E and hepatocellular carcinoma: In contrast to N-glycosylation, which was recently reported to attenuate CD73 activity in human hepatocellular carcinoma [8], ARTC1-mediated mono-ADP-ribosylation takes place at the cell surface and depends on the availability of NAD+ in the extracellular microenvironment.